Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in NRIX — Nurix Therapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to NRIX Full portfolio

Position in NRIX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$35,832,480
+$15,005,130 QoQ
Shares Held
1,477,019
+9.9% QoQ
Ownership
1.42%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#20
of 210 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NRIX Over Time

Shares Held

Position Value (USD)

Derivatives in NRIX

reported options exposure · as of Jun 30, 2026
CallValue
$994,660
CallShares
41,000
PutValue
$276,564
PutShares
11,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,839,618 across 436 Biotechnology names. NRIX ranks #36 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in NRIX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $276,564 11,400
2026-06-30 $994,660 41,000
2026-06-30 $35,832,480 1,477,019
2026-03-31 $567,300 36,600
2026-03-31 $20,827,350 1,343,700
2025-12-31 $21,871,082 1,152,930
2025-12-31 $644,980 34,000
2025-09-30 $5,223,417 565,305
2025-09-30 $104,412 11,300
2025-09-30 $269,808 29,200
2025-06-30 $18,099,107 1,589,035
2025-06-30 $128,707 11,300
2025-06-30 $455,600 40,000
2025-03-31 $93,852 7,900
2025-03-31 $68,904 5,800
2025-03-31 $15,651,400 1,317,458
2024-12-31 $561,432 29,800
2024-12-31 $16,042,617 851,519
2024-12-31 $182,748 9,700
2024-09-30 $34,406,175 1,531,205
2024-09-30 $233,688 10,400
2024-09-30 $366,261 16,300
2024-06-30 $21,718,698 1,040,666
2024-06-30 $753,407 36,100
2024-06-30 $202,439 9,700
2024-03-31 $3,156,325 214,716
2024-03-31 $63,210 4,300
2024-03-31 $17,640 1,200
2023-12-31 $124,872 12,100
2023-12-31 $60,888 5,900
2023-12-31 $328,887 31,869
2023-09-30 $538,157 68,468
2023-09-30 $49,518 6,300
2023-09-30 $88,032 11,200
2023-06-30 $122,877 12,300
2023-06-30 $154,505 15,466
2023-06-30 $1,247,751 124,900
2023-03-31 $18,648 2,100
2023-03-31 $1,355,976 152,700
2023-03-31 $501,630 56,490
2022-12-31 $5,490 500
2022-12-31 $1,308,892 119,207
2022-12-31 $1,571,238 143,100
2022-09-30 $1,048,915 80,500
2022-09-30 $1,806,986 138,679
2022-06-30 $1,420,307 112,100
2022-03-31 $1,220,271 87,100
2022-03-31 $2,967,079 211,783
2021-12-31 $1,542,426 53,279
2021-12-31 $289,500 10,000

Report a Problem

Category
Description
Email (optional, for follow-up)